AKUMS DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹850 Cr | ₹-52 Cr | ₹1,462 Cr | ₹1,246 Cr | ₹1,153 Cr |
What is the latest Total Non-Current Liabilities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹850 Cr |
| Mar2025 | ₹-52 Cr |
| Mar2024 | ₹1,462 Cr |
| Mar2023 | ₹1,246 Cr |
| Mar2022 | ₹1,153 Cr |
How is Total Non-Current Liabilities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹850 Cr | Positive | |
| Mar2025 | ₹-52 Cr | Negative | |
| Mar2024 | ₹1,462 Cr | 17.35 | |
| Mar2023 | ₹1,246 Cr | 8.11 | |
| Mar2022 | ₹1,153 Cr | - | |
Compare Total Non-Current Liabilities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹10,415.9 Cr | -5% | 6% | 24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | -5% |
6% |
24% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses